Combination Therapy for Antimicrobial Resistance
Combination therapy for antimicrobial resistance involves the use of two or more antimicrobials to treat infections that are resistant to single drugs. This approach is designed to enhance efficacy, reduce the development of resistance, and improve patient outcomes. By targeting multiple pathways or mechanisms of action, combination therapy can overcome resistance mechanisms employed by pathogens. It is particularly effective against multidrug-resistant bacteria and infections that are difficult to treat with conventional antibiotics alone.
Related Conference of Combination Therapy for Antimicrobial Resistance
July 20-21, 2026
7th International Conference on Applied Microbiology and Infectious Diseases
London, UK
August 27-28, 2026
12th International Congress on Trauma, Critical Care and Emergency Medicine
Paris, France
September 07-08, 2026
21st International Conference on Virology, Emerging Diseases & vaccines
London, UK
November 16-17, 2026
9th International Conference on Antimicrobial and Antibacterial Agents
Tokyo, Japan
November 16-17, 2026
10th International Conference on Microbiome, Probiotics & Gut Nutrition
San Francisco, USA
